COVID-19 Crisis: Bhutan to provide liquid oxygen to India
(PTI Photo)
Thimphu: Bhutan will supply life-saving liquid oxygen to India which is battling an unprecedented second wave of the COVID-19 pandemic, signalling a practical manifestation of the uniquely close and friendly bilateral ties, the Indian embassy here said on Tuesday.
Every day, 40 metric tonnes of liquid oxygen produced by the oxygen plant will be exported to Assam using cryogenic tankers, the embassy said in a statement.
The liquid oxygen to India will be supplied from the new plant being set up at the Motanga Industrial Estate, Samdrup Jongkhar district by a Bhutanese company, S D Cryogenics Gases Private Limited, it said.
Bhutan to provide liquid oxygen to India to help combat COVID-19
Every day, 40 metric tonnes of liquid oxygen produced by the oxygen plant will be exported to Assam using cryogenic tankers, the embassy said in a statement.
Share Via Email
| A+A A- By PTI
THIMPU: Bhutan will supply life-saving liquid oxygen to India which is battling an unprecedented second wave of the COVID-19 pandemic, signalling a practical manifestation of the “uniquely close and friendly” bilateral ties, the Indian embassy here said on Tuesday.
Every day, 40 metric tonnes of liquid oxygen produced by the oxygen plant will be exported to Assam using cryogenic tankers, the embassy said in a statement.
Medical supplies poured into India on Tuesday as hospitals turned away patients due to a shortage of beds and oxygen supplies and a surge of infections pushed the COVID-19 death toll towards 200,000. Read on for the latest updates on COVID-19 in India. A worker wearing personal protection equipment (PPE) loads wood onto a cart at a crematorium on the outskirts of New Delhi, India, on Friday, April 23, 2021. Image Credit: Bloomberg
But the crisis in the metropolis of 20 million people, the epicentre of the latest wave of infections, continued unabated. Dr K.Preetham, chief of medical administration at Delhi’s Indian Spinal Injuries Centre, said the scarcity of oxygen was the main concern.